Market revenue in 2023 | USD 129.3 million |
Market revenue in 2030 | USD 255.2 million |
Growth rate | 10.2% (CAGR from 2023 to 2030) |
Largest segment | Infectious diseases |
Fastest growing segment | Infectious Diseases |
Historical data | 2021 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Infectious Diseases |
Key market players worldwide | Danaher Corp, Kaneka Corp, TriLink BioTechnologies, Apex Biotechnology, BioNTech SE ADR, Lonza Group Ltd, Nunn’s Home Medical Equipment, EQT Corp, Catalent Inc, Samsung Electronics Co Ltd, Biomay AG, Indication, eTheRNA immunotherapies, BioCina |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to mrna therapeutics contract development & manufacturing market will help companies and investors design strategic landscapes.
Infectious diseases was the largest segment with a revenue share of 100% in 2023. Horizon Databook has segmented the Italy mrna therapeutics contract development & manufacturing market based on infectious diseases covering the revenue growth of each sub-segment from 2021 to 2030.
Growing R&D activities in Italy due to various funds & grants offered by government & nongovernment organizations for medical research are expected to boost the market. For instance, in April 2022, IRBM SpA received finance from the European Investment Bank totaling USD 16 million to expand the company’s R&D capabilities between 2022 and 2024.
This funding was anticipated to enhance the company’s research into infectious diseases to combat the spread of coronavirus in the region. As a result, the demand for mRNA therapeutics contract development and manufacturing is expected to grow in the country due to increased investment in biomedical research for the development of mRNA-based therapies.
The European Medicines Agency and Italian Medicine Agency (AIFA) are key government bodies responsible for the approval of mRNA-based therapeutics and vaccines in Italy.
Horizon Databook provides a detailed overview of country-level data and insights on the Italy mrna therapeutics contract development & manufacturing market , including forecasts for subscribers. This country databook contains high-level insights into Italy mrna therapeutics contract development & manufacturing market from 2021 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account